Home
Live Updates
New Guidance in Lowering LDL-C : comparemela.com
New Guidance in Lowering LDL-C
A panel of cardiologists discuss the key updates from the 2022 ACC Expert Consensus Decision Pathway on the role of nonstatin therapies for LDL-C lowering in the management of atherosclerotic cardiovascular disease risk.
Related Keywords
Bogalusa ,
Louisiana ,
United States ,
Payal Kohli ,
Christiem Ballantyne ,
Keithc Ferdinand ,
Erind Michos ,
,
Cardiology Expert Consensus Decision Pathway ,
Bogalusa Heart Study ,
Consensus Decision Pathway ,
South Asian ,
Ldl C ,
Cardiovascular Disease ,
Cardiovascular Risk ,
Hyperlipidemia ,
Primary Prevention ,
Secondary Prevention ,
Ascvd ,
Statins ,
High Risk ,
Lifetime Risk Of Ascvd ,
comparemela.com © 2020. All Rights Reserved.